Wu Manran, Zhang Lei, Shi Kexin, Zhao Dongxu, Yong Weipeng, Yin Lingling, Huang Ruizhe, Wang Guanglin, Huang Gang, Gao Mingyuan
State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.
Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
ACS Appl Mater Interfaces. 2023 Mar 15;15(10):12669-12677. doi: 10.1021/acsami.2c19829. Epub 2023 Feb 28.
Transarterial radioembolization (TARE) is a local radionuclide therapy and is successfully used in hepatocellular carcinoma (HCC) treatment. Radioactive microspheres have been widely studied for TARE. Preparation of ideal radioactive microspheres is significant for clinical research and patient treatment. In this study, we have designed a novel multifunctional microsphere, i.e., polydopamine (PDA)-coated Lu-radiolabeled silica microspheres (MS) denoted as Lu-MS@PDA, which can be used for TARE and photothermal therapy (PTT). The radiostability of Lu-MS@PDA was significantly improved by coating Lu-MS with PDA. In addition, the coating of PDA makes microspheres have excellent photothermal performance. MicroSPECT/CT images showed that Lu-MS@PDA was accurately embolized and remained in the tumor during the observation time. At the time, it also showed that Lu-MS@PDA was very stable in vivo. Furthermore, the anti-tumor results demonstrated that TARE combined with PTT of Lu-MS@PDA can significantly inhibit tumor growth without obvious side effects. Lu-MS@PDA holds great potential as a promising radioactive microsphere for HCC.
经动脉放射性栓塞术(TARE)是一种局部放射性核素治疗方法,已成功应用于肝细胞癌(HCC)的治疗。放射性微球已被广泛用于TARE的研究。制备理想的放射性微球对临床研究和患者治疗具有重要意义。在本研究中,我们设计了一种新型多功能微球,即聚多巴胺(PDA)包覆的镥标记二氧化硅微球(MS),记为Lu-MS@PDA,可用于TARE和光热治疗(PTT)。通过用PDA包覆Lu-MS,显著提高了Lu-MS@PDA的辐射稳定性。此外,PDA涂层使微球具有优异的光热性能。MicroSPECT/CT图像显示,Lu-MS@PDA在观察期内被准确栓塞并保留在肿瘤中。同时,这也表明Lu-MS@PDA在体内非常稳定。此外,抗肿瘤结果表明,Lu-MS@PDA的TARE联合PTT可显著抑制肿瘤生长,且无明显副作用。Lu-MS@PDA作为一种有前景的HCC放射性微球具有巨大潜力。